NanoMed Pharmaceuticals® is an early-stage specialty pharmaceutical company developing therapeutic and diagnostic products to treat or detect disease. The company’s initial focus utilizes its Nanotemplate Engineering™ technology to develop cancer therapeutics and diagnostics. Nanotemplate Engineering is a nanoparticle manufacturing technology used to formulate small molecules, peptides, proteins, plasmid DNA, and diagnostic agents. The company is headquartered in Kalamazoo, Michigan with research and development operations located at the University of Kentucky’s Advanced Science & Technology Commercialization Center (ASTeCC).
NanoMed was founded in 2000 by Russell Mumper, Ph.D. and Michael Jay, Ph.D., University of Kentucky College of Pharmacy faculty members and the inventors of the advanced drug delivery technologies the company has licensed from the University of Kentucky Research Foundation. Stephen Benoit joined NanoMed in 2001 as CEO.
The company's labs are located at the University of Kentucky’s Advanced Science & Technology Commercialization Center. NanoMed's corporate headquarters is located at M-TEC in The Groves Business Park in Kalamazoo, Michigan.